Vimarsana
Biggest News Aggregation in the World

Page 12 - Euronext News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Euronext. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Euronext Today - Breaking & Trending Today

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS - Vimarsana News

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION OF MASITINIB IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Paris, 29 May, 2024, 6pm CET AB...

AB Science: towards a negative opinion from the CHMP, listing suspended - Vimarsana News

AB Science: towards a negative opinion from the CHMP, listing suspended

AB Science announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a trend towards a negative opinion on the conditional marketing...

Journey Advisory Group LLC Has $943,000 Stock Position in Invesco S&P 500 Equal Weight ETF (NYSEARCA:RSP) - Vimarsana News

Journey Advisory Group LLC Has $943,000 Stock Position in Invesco S&P 500 Equal Weight ETF (NYSEARCA:RSP)

Journey Advisory Group LLC trimmed its stake in shares of Invesco S&P 500 Equal Weight ETF (NYSEARCA:RSP – Free Report) by 8.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,973 shares of the company’s stock after selling 552 shares during the quarter. […]

Source: wkrb13.com
Bpost / : Disclosure of a transparency notification - Vimarsana News

Bpost / : Disclosure of a transparency notification

Disclosure of a transparency notification 29 May 2024 20:09 CEST Subscribe ...

Related Topics:
Company Name
GENFIT to Present Latest ACLF Research at EASL Congress™ 2024 - Vimarsana News

GENFIT to Present Latest ACLF Research at EASL Congress™ 2024

Lille , Cambridge , Zurich , May 29, 2024 - GENFIT , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today detailed...